A
Power Law company profile
Apotea
Biotech & Life Sciences · Stockholm, Sweden · Founded 2011 Unicorn
Valuation
$1.03B
Market cap · May/2026
Revenue
$874M
Latest reported FY
EBITDA
$72M
Latest reported FY
Investors
3 investors on Apotea's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series B+
3 investors entered at this stage
Global footprint
Where Apotea has talent and traffic
AI talent share
0.5%
of workforce is AI talent
(3 of 556 staff)
(3 of 556 staff)
Core AI20.36%
Other AI10.18%
Non-AI workforce55399.46%
Workforce by country
3
countries with
team presence
team presence
🇸🇪 Sweden99.3%
🇳🇵 Nepal0.4%
🇳🇱 Netherlands0.4%
Web traffic by country
8.1M
monthly visits
across markets
across markets
🇸🇪 Sweden99.1%
🇺🇸 United States0.2%
🇩🇰 Denmark0.2%
🇩🇪 Germany0.2%
🇳🇴 Norway0.1%
Market sentiment
What the market is saying about Apotea
An AI-synthesized read of the highest-engagement posts about Apotea on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Apotea on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.